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Abstract Following the cloning of the dopamine receptors we 
continued a search of the human genome for related genes. We 
searched an EST data base and discovered cDNA fragments 
encoding novel G protein-coupled receptor genes. The available 
GenBank sequence of one of these EST fragments howed that it 
encoded a receptor with closest similarity to the D2 dopamine 
and adrenergic receptors. This cDNA was used to isolate the 
gene (GPRI9), and the encoded receptor also demonstrated 
similarity with the neuropeptide Y receptor. The gene was 
mapped to chromosome 12, in region p13.2-12.3. Northern blot 
analysis revealed expression of GPRI9 in peripheral regions, and 
brain regions significantly overlapping with the D2 receptor gene 
expression. A sequence of the rat orthologue of GPRI9 was 
obtained and in situ hybridization analysis demonstrated a very 
abundant expression in rat brain. 
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I. Introduction 
Following our reports on the cloning of the D1, D5 and the 
related pseudogenes we continued a broad search for addi- 
tional and related members of this G protein-coupled receptor 
(GPCR)  gene family. We have utilized several technical strat- 
egies to isolate novel members of this gene family, belonging 
to many diverse classes. During this process we reported the 
characterization of many human genes encoding GPCRs,  
namely APJ [1], GPRI ,  GPR2,  and GPR3 [2], GPR4,  
GPR5, and GPR6 [3], GPR7,  and GPR8 [4], GPR9, 
GPR10, and GPR14 [5], GPR15 [6], GPR20, 21, 22 and 23 
[7]. In this report, we describe a novel human gene (presently 
named GPRI9)  encoding a putative receptor which has sig- 
nificant amino acid sequence identity with the D2 dopamine 
and neuropeptide Y families of  receptors. This gene, intron- 
less in the coding region, also has a distr ibution in brain over- 
lapping that of the D2 dopamine receptor gene, and is located 
on chromosome 12. 
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2. Materials and methods 
2.1. Searching the data base of expressed sequence tags 
We queried the data base of expressed sequence tags (EST) main- 
tained by the National Center for Biotechnology Information (NCBI), 
with different rhodopsin family G protein-coupled receptor amino 
acid sequences using the TBLASTN algorithm [8]. The dbEST se- 
quences returned that had statistically significant scores (E values 
< 0.05) were searched manually to determine whether highly con- 
served amino acid sequence motifs (e.g. N/DPXXY) were present in 
the translated sequences. The conceptualized amino acid sequences 
were then used to query our G protein-coupled receptor data base 
to eliminate from further consideration those EST sequences that 
represented known G protein-coupled receptors. The amino acid se- 
quences thus filtered were used to query the SwissProt (release 31) 
data base using the FASTA algorithm (BLOSSUM 50 matrix, 
ktup = 1) [9,10] and those sequences that scored significantly (E value 
<0.01) against more than one known G protein-coupled receptor 
were retained. The EST cDNAs representing sequences that met these 
criteria were requested from the I.M.A.G.E. Consortium. The re- 
ported nucleotide sequences were verified by sequencing of both 
ends of the cDNA. 
2.2. Human library screening and PCR amplification of rat genomic 
DNA 
The EST fragment (I.M.A.G.E.I.D. #45231), a 1.4 kb cDNA in- 
serted in the lafmid vector at the HindlII/Notl sites, was used to 
screen a human ~EMBL3 SP6/T7 (Clontech) genomic library as pre- 
viously described [2]. The probe binding phage clones were purified, 
digested with restriction enzymes, and subjected to Southern blot 
hybridization with the same probe used to screen the library. The 
DNA fragments were isolated, subcloned into pBluescript and se- 
quenced. Rat genomic DNA was amplified by PCR using degenerate 
oligonucleotides (5'-ATGGAATTAAGTGAGGAGCAC and 5'- 
AATGAGTCATAGATCGAGTC) designed based on the sequence 
of the human EST fragment. Rat genomic DNA (1 ~tg) was amplified 
with these primers, under the following conditions: 1.5 min at 95°C, 
2 min at 50°C, and 4 min at 73°C for 30 cycles. The PCR product was 
subcloned as described previously [2]. 
2.3. Northern blot analysis 
RNA samples from different brain regions and tissues were ex- 
tracted as previously described [11]. Briefly, total RNA was extracted 
by the method of Chomczynski and Sacchi [12] and polyA + RNA was 
isolated using oligo-dT cellulose spin columns (Pharmacia). RNA was 
denatured and size fractionated on a 1% formaldehyde agarose gel, 
transferred onto nylon membrane and immobilized by UV crosslink- 
ing. The blots were probed with a 32p-labeled fragment, washed with 
2× SSC, 0.1% SDS at 50°C for 20 rain and with 0.1 xSSC, 0.1% SDS 
and exposed to X-ray film for 3 days at -70°C with an intensifying 
screen. 
2.4. In situ hybridization analysis 
Male rats (Charles River, ~ 200-250 g) were killed by decapitation 
and brains removed in 30 s and frozen in crushed dry ice. Frozen 
All rights reserved. 
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Fig. 1. Amino acid comparison of the putative receptor encoded by GPR19 with related G protein-coupled receptors. The protein encoded by 
GPR19 is compared with the human D2 receptor, and neuropeptide Y2 receptor. Amino acids identical with the protein encoded by GPR19 
are boxed and shaded. The predicted seven-transmembrane domains are indicated. Gaps ( - )  have been introduced to maximize the alignments 
among the sequences. The GenBank Accession umbers for human and rat GPR19 are U64871 and U65417, respectively. 
brains were sectioned at 14 p.m thickness on a Reichert-Jung cryostat 
at -20°C and thaw-mounted onto microscope slides. Sections were 
fixed in freshly prepared 4% paraformaldehyde in 0.02%, DEPC water 
for 20 min at 4°C in an ice bath and then washed for 5 min in cold 
phosphate-buffered saline, pH 7.4 before dehydration in an alcohol 
series, as described previously [11]. Fixed sections were stored at 
-70°C until use. 
The PCR derived rat orthologue of GPR19 was labeled by random 
priming using [aSS]dCTP (NEN, Dupont). Rat brain sections were 
prehybridized for 2 h in buffer containing 50% deionized formamide, 
0.6 M NaCI, 10 mM Tris-HCl pH 7.5, 10% dextran sulfate, 1% poly- 
vinyl pyrrolidone, 2% SDS, 100 mM dithiothreitol, 200 lag/ml herring 
sperm DNA, and hybridized with the labeled probe (106 cpm/slice) for 
16 h, and washed in conditions of increasing temperature and decreas- 
ing ionic strength. The hybridized sections were dehydrated in a 
graded alcohol series and were exposed to X-ray film (Dupont 
MRF-34) for 4 weeks at -70°C and developed. For use as controls, 
adjacent sections were hybridized following treatment with RNase, to 
confirm the specificity of hybridization. 
2.5. FISH detection 
Phage probes were biotinylated with dATP using the BRL Bionick 
labeling kit. For in situ hybridization and FISH detection, lympho- 
cytes were cultured and synchronized as described [13]. The cells were 
harvested and slides were made. The procedure for FISH was per- 
formed as previously described [13]. 
2.6. Single stranded conforrnational polymorphism ( SSCP ) analysis 
The SSCP method was used to screen GPR19 for polymorphic 
variants. The intronless gene was divided into five overlapping seg- 
ments using overlapping primer pairs and the amplified gene frag- 
ments were obtained from the PCR. The reaction was conducted 
using 0.2 mM of each primer, 1.5 mM MgCI~ and 2.5 units Taq 
polymerase. The PCR product was denatured for 5 min at 95°C 
and soaked for 5 min at 4°C prior to loading the SSCP gel. The 
denaturing running buffer consisted of 40% denaturing solution 
(0.12% SDS and 10 mM EDTA) and 60% stop solution (95% forma- 
mide, 20 mM EDTA, 0.05% bromophenol blue and 0.05% xylene 
cyanol). 
The SSCP was conducted using Novex 4-20% precast gels run in 
the Novex Xcell II mini-cell system. The gels were typically run at 50 
volts for 14 h overnight and developed using the Novex Silver Xpress 
staining kit. 
2. 7. Radioligand binding assays 
Using primers flanking the coding region of GPR 19 we amplified by 
PCR this fragment and subcloned this DNA into the expression vec- 
tor pcDNA3 (Invitrogen). The DNA construct was used to transiently 
transfect COS cells, and membranes from these cells were tested for 
their ability to bind a variety of ligands. Expression of GPR19 in COS 
cells was verified by Northern blot analysis. 
3. Results and discussion 
3.1. Cloning of the gene GPR19 
Using a customized search procedure of a human EST data 
base, several cDNA sequences that partially encoded novel 
GPCRs were identified. One of these EST fragments obtained 
from the I .M.A.G.E Consortium (I.D. #45231; GenBank ac- 
cession number H07970) is 1.4 kb long and on further sequen- 
cing it was determined to contain the entire coding sequence 
of a novel GPCR, with 35 base pairs in the 5' untranslated 
region. To obtain the gene encoded by this EST fragment, a 
human genomic library was screened and 6 positive clones 
were obtained. One of these phage was purified and after 
restriction and Southern blot analysis, a 5-kb fragment was 
subcloned and sequenced. This genomic lone, which we have 
called GPR19, contained an intronless open reading frame of 
1245 nucleotides (identical to the cDNA clone), encoding a 
415 amino acid protein (Fig. 1). PCR analysis of the rat ge- 
nome using two oligonucleotides specific for the coding region 
of the human gene, also identified a DNA fragment of the 
predicted size. The DNA fragment was subcloned and se- 
quenced and demonstrated 85% nucleotide identity with hu- 
man. This rat genomic clone of GPR19 was used to map the 
distribution of mRNA transcripts in the rat brain. 
Hydrophobic analysis of the deduced amino acid receptor 
sequence encoded by GPRI9,  demonstrated the seven TM 
regions characteristic of all GPCRs. A search of the GenBank 
data base, followed by a manual alignment, revealed that 
overall the protein sequence had significant sequence similar- 
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ity both with the dopamine D2 receptor family, and the neu- 
ropeptide Y receptors. A comparison of the TM regions of the 
receptor sequence ncoded by GPR19 with the D2 dopamine 
and neuropeptide Y receptor, revealed that there were 101 and 
95 amino acids identical, respectively (Fig. 1). Furthermore a 
comparison with all three members of the D2 receptor family 
(D2, D3 and D4) revealed that overall 130 amino acids were 
identical. To a lesser extent similarity was also revealed, by 
the GenBank search with the cholecystokinin receptor and 
two other aminergic muscarinic and adrenergic receptors. 
The novel receptor contains three putative glycosylation 
sites, consensus equences for phosphorylation by protein ki- 
nase C in the intracellular loops, and a cysteine for potential 
modification by palmitoylation i the carboxy tail. The car- 
boxy tail contains a stretch of 6 amino acids of which five are 
either serines or threonines and may be targets for phosphor- 
ylation by GPCR kinases. Significantly, an aspartic acid resi- 
due that forms part of the ligand binding site in the catechol- 
aminergic receptors in TM3 was absent, indicating that the 
endogenous ligand is likely not aminergic. 
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Fig. 2. Northern blot analysis of the tissue distribution of GPR19 
mRNA in human brain (top panel), rat brain (middle panel), and 
rat peripheral tissues (lower panel). Each lane contained 5 ~tg of 
poly(A) + RNA isolated from various human and rat tissues. The 
human blot was probed with a 1.4 kb fragment isolated from the 
coding region of GPR19. The rat blots were probed with the rat 
orthologue of GPRI9. 
Fig. 3. Darkfield autoradiograms of coronal sections of rat brain 
showing the localization of GPR19 receptor mRNA. Shown are rep- 
resentative sections at levels relative to the bregrna t -0.0 mm (A) 
and -3.3 mm (B), according to the coordinates [14]. Acb, nucleus 
accumbens; ACg, anterior cingulate cortex; AHi, amygdala; Arc, 
arcuate nucleus; CA1 and CA2, hippocampus regions; CPu, cau- 
date putamen; DG, dentate gyrus; FrP, frontoparietal cortex; ICj, 
islands of Calleja; LS, lateral septum; MHb, medial habenula; 
OTu, olfactory tubercle; PO, piriform area; VMH, ventromedial 
nucleus of hypothalamus; ZI, zona incerta. 
3.2. Expression of GPR19 
Northern blot analysis studies using poly(A) + RNA iso- 
lated from multiple human and rat brain and peripheral re- 
gions revealed a single mRNA transcript for gene GPRI9. In 
human brain the signal was strongest in the caudate nucleus 
and putamen, followed by thalamus. Fainter signals were 
noted in frontal cortex and hypothalamus with two transcripts 
observed in pituitary (Fig. 2). In rat tissues a single mRNA 
transcript was visualized in all regions examined. There was 
relatively greatest abundance of expression of GPR19 mRNA 
in brain (overlapping D2 receptor expression), with succes- 
sively lesser amounts in kidney, heart, spleen, liver and ovary. 
Only a faint signal was observed in lung tissue, and a mod- 
erate level of expression was present in rat fetus. In the North- 
ern blot analysis of rat brain regions the greatest abundance 
was in the pituitary and cerebellum, followed by olfactory 
tubercle and thalamus. Significant GPR19 mRNA expression 
was also present in striatum, hippocampus, frontal cortex, 
hypothalamus and medulla pons. 
In rat brain sections, the distribution of GPR19 mRNA 
showed discrete localization in many areas. As shown in 
Fig. 3, mRNA was detected in several cortical regions such 
as the somatosensory areas, anterior limbic area, piriform 
area and the posterior limbic area including the retro- 
splenium. GPR19 mRNA was densely localised to the olfac- 
tory tubercle, islands of Calleja, hippocampal reas and den- 
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Fig. 4. FISH analysis of GPR19. A: Results of metaphase pread 
chromosomes probed with a phage clone encoding GPRI9. Arrows 
point to the FISH signals on a pair of chromosomes. B: A sum- 
mary of the FISH analysis, each dot represents he location of a 
fluorescent signal on the chromosome using phage GPR19 as ap- 
robe. 
tate gyrus, mRNA was also detected in several amygdaloid 
nuclei and hypothalamic nuclei, and lower levels were present 
in ventral tegmental rea, substantia nigra compacta nd cen- 
tral gray. 
3.3. Chromosomal ssignment of GPR19 
Fluorescence in situ hybridization (FISH) of lymphocyte 
metaphase pread chromosomes was used to identify the chro- 
mosomal location of the gene GPR19. Under the conditions 
used, the hybridization efficiency of the phage probe contain- 
ing GPR19 was 95%; among 100 checked mitotic figures, 96 
showed signals on one pair of the chromosomes. To assign the 
signal to a specific chromosome the DAPI banding pattern 
was examined. These results indicate that GPR19 is located 
on chromosome 12 in region p13.2-12.3, the data are sum- 
marized in Fig. 4. 
3.4. Pharmacological characterization of the receptor encoded 
by gene GPR19 
Membranes from COS cells transiently transfected with 
GPR19 were tested for their ability to bind a variety of lig- 
ands. No saturable binding was detected with tritium-labeled 
haloperidol, spiperone, nemonapride, mesulergine, naloxone, 
butaclamol, clozapine, DTG, flupenthixol, or LSD. Mem- 
branes from COS cells transfected with GPR19 were also ex- 
amined for activation of adenylyl cyclase activity in the pres- 
ence and absence of forskolin, following the addition of a 
variety of ligands. No effects on adenylyl cyclase activity 
were seen with dopamine, serotonin, epinephrine, (-)sulpir- 
ide, HVA, 2-hydroxyestradiol, 4-hydroxyestrone and 4-hydro- 
xy-3-methoxyphenyl gl col. 
3.5. Polymorphic variants of  GPR19 
SSCP analysis was used to identify three polymorphic var- 
iants of GPR19 and each was confirmed by sequencing. The 
first resulted in an amino acid change of isoleucine 289 to 
valine in TM 4 of the receptor, as a result of a single base 
substitution. The frequency of this allele was 6.5% in Cauca- 
sians (n = 200), and occurred more commonly in blacks (15%; 
n = 88). A second polymorphism with a frequency of 1.5%, 
was located in TM 2 of the receptor and represented an amino 
acid change from valine 116 to isoleucine as a result of a 
single base change. The third polymorphism found in a single 
individual was a substitution (G for A) at base pair 1062. The 
first polymorphism noted by virtue of its significant incidence 
may facilitate linkage analysis of neuropsychiatric diseases. 
In summary, we have identified a novel gene encoding a
putative receptor with extensive and abundant distribution 
in brain and periphery. The abundant distribution of 
GPR19 mRNA in brain regions such as olfactory tubercle, 
islands of Calleja, caudate-putamen and pituitary are very 
similar to the expression pattern of the D2 receptor gene. 
Further work is necessary to identify the endogenous ligand 
which will likely have important neurotransmitter function. 
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